Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

A new treatment for hair loss shows promise with fewer side effects.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Fernblock® helps protect skin cells from pollution and stress, reducing inflammation and damage.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

The compound 4c showed strong potential as an anticancer agent.

Analog 23 is a promising compound for prostate cancer treatment.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

New compounds with carborane showed anti-androgen effects similar to flutamide.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

5α-reductase 2 is crucial for stress response in male rats.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.